Navigation Links
Genisphere Appoints New CEO, Thomas Bliss
Date:6/30/2015

HATFIELD, Pa., June 30, 2015 /PRNewswire/ -- Genisphere announced Tom Bliss has joined the company as CEO to help further develop Genisphere's therapeutics capabilities and portfolio. Mr. Bliss comes with a wealth of partnering experience, having spent much of the last 25 years in leadership positions at biopharmaceutical companies including Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom started his career in Investment Banking, with a focus on Technology and Biotech Corporate Finance. He graduated from Dartmouth College with a BA in English and Asian Studies (Mandarin), and completed his MBA at The Wharton School, University of Pennsylvania in Finance and Marketing.

Logo - http://photos.prnewswire.com/prnh/20150629/226697LOGO

Tom joins Genisphere as the Company pivots to focus more resources on its emerging therapeutic portfolio, having established its diagnostics business with key strategic partners. "I am excited to start a new challenge with Genisphere, and look forward to working with the team to develop and expand their pharmaceutical collaborations. I know Genisphere has already had substantial success demonstrating our unique 3DNA technology and I'm sure success will accelerate as additional data are generated."  

Dr. Robert Getts, Chief Science Officer, commented, "Tom's wealth of experience and industry knowledge has already made him a key addition to the Genisphere family. Our new innovations led us to look for an experienced leader for our team who will fit in with the company culture, and I'm sure he will make immediate positive contributions." James Kadushin, Chief Operating Officer, said, "I look forward to working with Tom. It is very fortunate that we were able to find someone with deep pharmaceutical development and partnering experience to fulfill this role."

About Genisphere
Genisphere LLC is a targeted drug delivery platform company. Genisphere's platform is a DNA-based nanotechnology called 3DNA®. 3DNA® nanocarriers are used to deliver drugs in a highly targeted manner. Genisphere's technology is IP-protected and fully customizable to deliver a variety of therapeutics including small drugs, biologics, and nucleic acids. 3DNA® nanostructures are composed entirely of DNA, engineered and cross-linked to form a stable architecture while maintaining the biocompatibility of the nucleic acid building blocks. Genisphere has been leveraging a collaborative model to advance its drug delivery platform, and continues to seek partnerships with biotechnology and pharmaceutical companies that could benefit from the company's platform technology. Genisphere is also advancing its own lead compounds based on the 3DNA® platform. For more information, please visit http://genisphere.com

For more information contact:

Dr. Robert Getts
Genisphere 
215-996-3027
Email


'/>"/>
SOURCE Genisphere LLC
Copyright©2015 PR Newswire.
All rights reserved

Related biology news :

1. Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer
2. MedNet Appoints Clareece West As Chief Operating Officer
3. Profil Institute Appoints Dan Bradbury, former Amylin Pharmaceutical CEO, to Board of Directors
4. EyeLock Appoints Roger An Vice President of Global Market Development
5. EyeLock Appoints Michael Fiorito Vice President of Enterprise Accounts
6. EyeLock Appoints Darlene Crumbaugh Vice President of Financial Services
7. Techne Corporation Appoints Dr. J. Fernando Bazan As Chief Technology Officer
8. BioNano Genomics Appoints Dr. Fahim Amini As Vice President Commercial Operations EMEA
9. Homeland Security Corporation (HSCC) Appoints New President with Biometrics and Access Control Solutions Expertise and Contacts
10. Neurobiologist Thomas Jessell to receive $500,000 Gruber Neuroscience Prize
11. Its not all wedded bliss: Marital stress linked to depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2019)... ... March 18, 2019 , ... 3Bar ... microbial solutions announce today they have entered into an agreement for 3Bar to ... for biologic nitrogen fixation for corn. This agreement ensures an easy-to-use solution for ...
(Date:3/13/2019)... ... 2019 , ... Sleep problems constitute a global epidemic that threatens health and ... One billion people worldwide suffer from sleep apnea - a condition that ... of whom go undiagnosed. Today, Beddr , the sleep health technology startup, announced ...
(Date:3/9/2019)... ... March 07, 2019 , ... Murrieta Genomics , ... full day workshop presented by University of California Riverside’s EPIC SBDC focused on ... a.m. to 6 p.m. on Tuesday, March 17, 2019. The location is the Highlander ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... The growth ... challenges for companies to keep up. Traditional Regulatory intelligence (RI) ... adapting technology to get global Regulatory teams right Insights faster and cheaper. With a ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... for preclinical research organizations. It is a low code, GDPR/21 CFR Part ... facilities, innovative technology-driven automated data capture and seamless data and information management. ...
(Date:3/9/2019)... (PRWEB) , ... March 07, 2019 , ... ... is a pioneer in the development and commercialization of high performance, cutting-edge cell ... a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are ...
(Date:2/27/2019)... ... 27, 2019 , ... Lajollacooks4u is pleased to announce that ... and cooking events company will be offering a new cooking package available to ... team-building event involves pairing two popular items together – tacos and tequila – ...
Breaking Biology Technology: